IGF2R; CD222; CIMPR; M6P R; MPR1; MPRI; M6PR; CI-MPR; MPR 300; M6P/IGF2R; IGF-II receptor
Predicted N Terminal
Lyophilized from a 0.2 μm filtered solution in PBS.
Measured by its binding ability in a functional ELISA. When Recombinant Human IGF-II R is immobilized at 2 μg/mL (100 µL/well), the concentration of Recombinant Human CREG that produces 50% of the optimal binding response is found to be approximately 2 ‑ 10 ng/mL.
Predicted Molecular Mass: 147 (monomer) kDa
SDS-PAGE: 160-180 kDa, reducing conditions
<0.01 EU per 1 μg of the protein by the LAL method.
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain